Related Experiment Video
Updated: Sep 23, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion
Lluis Fajas1, Stephanie Miard, Michael R Briggs
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, B. P. 163, F-67404 Illkirch cedex, C.U. de Strasbourg, France.
Abstract:
Selective cyclo-oxygenase-2 (COX-2) inhibitors are nonsteroidal antiinflammatory drugs used in the management of inflammatory diseases. We demonstrate here that inhibition of the COX-2 enzyme impairs adipocyte differentiation. The inhibition of adipogenesis occurs in the early clonal expansion phase. In particular, COX-2 inhibition limits cell cycle reentry required before terminal adipocyte differentiation. This inhibition of adipogenesis is independent of the production of the peroxisome proliferator activated receptor gamma ligand prostaglandin J2, but dependent on the production of proliferative prostaglandins, such as prostaglandin E2. Modulation of the activity of the COX-2 enzyme via COX-2 selective inhibitors might open up new perspectives in the control of obesity and related metabolic diseases.
Insights
Selective cyclo-oxygenase-2 (COX-2) inhibitors hinder fat cell differentiation by blocking cell cycle reentry. This finding suggests COX-2 modulation may offer new strategies for managing obesity and metabolic diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Disease Research
Background:
- Selective cyclo-oxygenase-2 (COX-2) inhibitors are nonsteroidal anti-inflammatory drugs (NSAIDs).
- These drugs are commonly used for managing inflammatory conditions.
- The role of COX-2 in metabolic processes like adipogenesis is not fully understood.
Purpose of the Study:
- To investigate the effect of COX-2 inhibition on adipocyte differentiation.
- To determine the specific phase of adipogenesis affected by COX-2.
- To elucidate the molecular mechanisms underlying COX-2's role in adipogenesis.
Main Methods:
- Utilized selective COX-2 inhibitors in cell culture models.
- Assessed adipocyte differentiation markers and cell cycle progression.
- Analyzed the involvement of prostaglandin pathways (e.g., PGE2, PGD2).
Main Results:
- COX-2 inhibition significantly impaired adipocyte differentiation.
- The inhibition occurred during the early clonal expansion phase of adipogenesis.
- COX-2 blockade limited cell cycle reentry, a prerequisite for differentiation.
- This effect was independent of prostaglandin J2 but dependent on proliferative prostaglandins like prostaglandin E2.
Conclusions:
- COX-2 plays a critical role in regulating adipocyte differentiation.
- Inhibition of COX-2 disrupts the cell cycle progression necessary for adipogenesis.
- Modulating COX-2 activity presents a potential therapeutic avenue for obesity and related metabolic disorders.
Related Concept Videos
Inhibition of Cdk Activity
Cycloaddition Reactions: MO Requirements for Thermal Activation
Cycloaddition Reactions: Overview
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids
